Join us for our next Global Conference on Regulatory Science in October 2021!

Improving the Process of Therapeutic Development

Harvard, MIT, and the FDA have partnered to create a center focused on regulatory science, bringing together a range of scientific disciplines that are applied to assess the quality, safety and efficacy of medicinal products and inform regulatory decision-making throughout the lifecycle of a medicine. Working across academia, industry, and government institutions, the Center promotes regulatory science through research and education programs, uniting stakeholders under a common mission: promoting optimal patient health outcomes through biomedical innovation and the availability of safe and effective diagnostics and treatments.

The Regulatory Science Fellowship Program

Our fellowship program is affiliated with the FDA and focuses on training the next generation of regulatory science researchers. Learn more about the research our fellows are conducting or explore opportunities and how to get involved in our program.

News, Events, & Updates

Meet our newest fellow: Susmitha Wunnava

Learn more on Dr. Wunnava’s fellow spotlight

See Spotlight

RegSci Forum: Real-world COVID-19 Vaccine Effectiveness and the Mass Vaccination Experience in Israel

Ben Reis, BCH CHIP & HMS


April 16, 2021  11am-12pm ET*

Virtual Webconference

RSVP coming soon


*note new time

RegSci Forum: Benefit-Risk Analysis of Regulatory Decision-Making

GK Raju


May 11, 2021  12-1pm ET

Virtual Webconference